|
Market Closed -
Nasdaq
21:00:00 31/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 84.95 USD | +0.13% |
|
-.--% | +82.49% |
| Market Cap | 9.01B 8.17B 7.55B 6.82B 12.84B 850B 13.3B 90.75B 35.98B 454B 33.82B 33.1B 1,441B | P/E 2024 |
-13.8x | P/E 2025 | -9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 8.03B 7.28B 6.73B 6.08B 11.45B 757B 11.85B 80.89B 32.07B 405B 30.15B 29.51B 1,284B | EV / Sales 2024 |
3,310x | EV / Sales 2025 | 447x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CRNX | Delayed | |
| CRNX | Real-time |
Last Transcript: Crinetics Pharmaceuticals
| 1 day | +0.13% | ||
| 3 months | +0.30% | ||
| 6 months | +131.03% | ||
| Current year | +82.49% |
| Current year | 32.3 | 85.01 | |
| 1 year | 32.3 | 85.01 | |
| 3 years | 24.1 | 85.01 | |
| 5 years | 15.23 | 85.01 | |
| 10 years | 10.63 | 85.01 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Wagner
PSD | President | 57 | 31/08/2026 |
Cory Jubinville
PRN | Corporate Officer/Principal | - | 31/01/2026 |
Omar White
SEC | Corporate Secretary | - | 31/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Wagner
BRD | Director/Board Member | 57 | 31/08/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Issuer sale | Chief Financial Officer | -209,427 | 0.1986% | ||
| 01/09/26 | Issuer sale | Founder | -905,240 | 0.8585% | ||
| 01/09/26 | Issuer sale | Chairman | -232,151 | 0.2202% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.04M 942K 871K 786K 1.48M 97.97M 1.53M 10.46M 4.15M 52.33M 3.9M 3.82M 166M | 7.7M 6.97M 6.45M 5.82M 10.97M 726M 11.35M 77.49M 30.73M 388M 28.88M 28.27M 1.23B |
| Net income | -298M -270M -250M -226M -425M -28.14B -440M -3B -1.19B -15.03B -1.12B -1.1B -47.71B | -465M -422M -390M -352M -663M -43.87B -687M -4.69B -1.86B -23.44B -1.75B -1.71B -74.39B |
| Net Debt | -1.3B -1.18B -1.09B -985M -1.86B -123B -1.92B -13.11B -5.2B -65.6B -4.89B -4.78B -208B | -979M -887M -821M -741M -1.4B -92.34B -1.44B -9.86B -3.91B -49.33B -3.68B -3.6B -157B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CRNX Stock
Select your edition
All financial news and data tailored to specific country editions
















